The BioNJ Diagnostics and Personalized Medicine Committee was created to advance personalized medicine through diagnostics by identifying and supporting partnerships with industry, academic, government and investors in the State of New Jersey.
The goal of the committee is to define and accelerate new areas of diagnostics, such as in vivo and in vitro tests, biomarkers, imaging, information systems and other innovative technologies.
June 6, 2013: Second Annual Diagnostics & Personalized Medicine Innovation Summit
December 13, 2012: Diagnostics & Personalized Medicine Breakfast Briefing
March 14, 2012: Diagnostics and Personalized Medicine Innovation Summit & Funding Roundtable
May 23-24, 2011: BioPartnering Conference: Bringing Together the Biotech, Diagnostics and Big Pharma Communities.
May 5, 2011: Diagnostics and Personalized Medicine Webinar
September 2010: New Jersey Gets Personalized Breakfast Briefing
July 2010: Kickoff Diagnostic Webinar Featuring G. Steven Burrill
Peter Hoehn, Committee Co-Chair, Global Business Leader, Janssen Diagnostics
Pascal Yvon, PharmD, MBA, Committee Co-Chair, President, BioSciences Expansion
Andrew Brooks, Ph.D., Chief Operating Officer, RUCDR, Infinite Biologics
Ger Brophy, B.Sc., Ph.D., General Manager, New Product Development, Medical Diagnostics, GE Healthcare
Shana Fried, Senior Associate, Reed Smith LLP
Guanghui Hu, President, Admera Health
Courtney Kronenthal, Ph.D., Director, Communications & Development, Coriell Institute for Medical Research
Nancy Lurker, Chief Executive Officer, PDI Inc.
Janet McKim, Director of Development, Human Genetics Institute of NJ, RUCDR, Infinite Biologics
Joe Montemarano, MIRTHE Executive Director, Princeton University
Christopher Moxham, Ph.D., Associate Vice President, ImClone Systems, a wholly owned subsidiary of Eli Lilly and Co.
Roomi Nusrat, M.D., Aesclepius Sciences
Lieven Nuyttens, Chief Executive Officer, US Division, FluidDA, Inc.
Kathleen Otto, Vice President, Business Development, BioNJ
Kapila Ratnam, Principal, NewSpring Capital
Panna Sharma, President & Chief Executive Officer, Cancer Genetics, Inc.
Jacqueline Threadgill, Senergene Solutions
Peter Tolias, Ph.D., Director, Center for Healthcare Innovation and Professor, Department of Chemistry, Chemical Biology and Biomedical Engineering, Stevens Institute of Technology